跳至主要内容
临床试验/ISRCTN87325378
ISRCTN87325378已完成不适用

ow molecular weight heparin (FRagmin®) in pregnant women with a history of Uteroplacental Insufficiency and Thrombophilia: a randomised trial

VU University Medical Center (The Netherlands)0 个研究点目标入组 154 人开始时间: 2005年12月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
154

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients with a history of preeclampsia and/or small for gestational age infants before 34 weeks gestation and documented thrombophilia restricted to protein C and protein S deficiency, Activated Protein C (APC) resistance, Factor V Leiden mutation, Factor II mutation, anticardiolipin antibodies, lupus anticoagulant
  • 2. Aged greater than 18 years
  • 3. Informed consent

排除标准

  • 1. Antithrombin deficiency
  • 2. Diabetes mellitus
  • 3. Known malignancy
  • 4. Gastro-duodenic ulcer
  • 5. Severe renal or hepatic insufficiency
  • 6. Thrombo-embolism in history
  • 7. Hemorrhagic diathesis
  • 8. Idiopathic thrombocytopenia

研究者

发起方
VU University Medical Center (The Netherlands)

相似试验

ow molecular weight heparin (FRagmin®) in pregnant... | 临床试验